Live Breaking News & Updates on Informed Data Systems
Stay updated with breaking news from Informed data systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ The global digital diabetes management market size is estimated to grow by USD 19.12 bn from 2024 to 2028, according to Technavio. The market. ....
/PRNewswire/ The Non-invasive Glucose Monitoring Devices Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027 report has been. ....
Bayer transforms pharma business through breakthrough innovation in healthcare 13:48 | 14/01/2021 Bayer has made exciting progress in transforming its pharmaceutical business with breakthrough innovations in healthcare that will significantly help patients suffering from conditions that are currently still difficult to treat. Bayer highlighted its focus on cell, gene, and oncology pipelines during its virtual Pharma Media Day in Germany The information was stressed at its virtual Pharma Media Day titled âTransforming Healthcare. Transforming Bayerâ in Germany. The event highlighted Bayer s focus on the cell, gene, and oncology pipelines. âThe biomedical and technological revolution that is transforming healthcare at an unprecedented pace is taking place now. Our company is at the forefront of the wave of innovation in cell and gene therapy as well as digital health,â said Stefan Oelrich, member of the board o ....
Bayer Updates Progress In Transforming Pharma Business Through Innovation In Healthcare LEVERKUSEN (dpa-AFX) - Bayer AG Wednesday updated its progress in transforming its pharmaceutical business with breakthrough innovation in healthcare. At its virtual Pharma Media Day, under the theme Transforming Healthcare. Transforming Bayer , the company revealed innovation in cell and gene therapy as well as digital health that will significantly help patients suffering from conditions that are currently still difficult to treat. Bayer said it recently heavily invested in external innovation with more than 25 collaboration agreements and acquisitions. Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer s Pharmaceuticals Division, said, We are driving this transformation and growing our promising development portfolio together with our partners. Our joint goal is to bring breakthrough treatments to patients and make healthcare systems more sus ....